Globe Life Inc. (NYSE:GL – Get Free Report) CEO Frank Svoboda sold 10,000 shares of the company’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $166.68, for a total transaction of $1,666,800.00. Following the transaction, the chief executive officer owned 54,020 shares of the company’s stock, valued at approximately $9,004,053.60. The trade was a 15.62% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.
Globe Life Stock Performance
Globe Life stock traded up $2.45 during trading hours on Monday, reaching $169.21. 206,975 shares of the stock were exchanged, compared to its average volume of 517,869. The stock has a market cap of $13.14 billion, a P/E ratio of 11.71 and a beta of 0.49. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life Inc. has a 52-week low of $116.73 and a 52-week high of $169.50. The firm’s 50 day moving average is $152.88 and its 200 day moving average is $144.60.
Globe Life (NYSE:GL – Get Free Report) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). The firm had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.56 billion. Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The firm’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.07 EPS. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Analysts predict that Globe Life Inc. will post 15.64 EPS for the current fiscal year.
Globe Life Dividend Announcement
Analyst Upgrades and Downgrades
GL has been the subject of a number of analyst reports. Keefe, Bruyette & Woods restated a “moderate buy” rating and set a $168.00 price objective on shares of Globe Life in a research report on Thursday, March 26th. Evercore set a $157.00 price objective on shares of Globe Life in a research report on Wednesday, February 18th. Wells Fargo & Company upped their price objective on shares of Globe Life from $171.00 to $172.00 and gave the stock an “overweight” rating in a research report on Friday, April 10th. Weiss Ratings upgraded shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday, May 13th. Finally, Texas Capital upgraded shares of Globe Life to a “strong-buy” rating in a report on Wednesday, March 18th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $174.11.
Check Out Our Latest Analysis on GL
Hedge Funds Weigh In On Globe Life
Large investors have recently made changes to their positions in the stock. Hilton Head Capital Partners LLC purchased a new position in shares of Globe Life in the 4th quarter valued at about $30,000. CYBER HORNET ETFs LLC purchased a new position in shares of Globe Life in the 2nd quarter valued at about $28,000. MUFG Securities EMEA plc purchased a new position in shares of Globe Life in the 2nd quarter valued at about $31,000. Torren Management LLC purchased a new position in shares of Globe Life in the 4th quarter valued at about $37,000. Finally, AdvisorNet Financial Inc increased its holdings in shares of Globe Life by 41.1% in the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after purchasing an additional 92 shares in the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.
Globe Life Company Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Read More
- Five stocks we like better than Globe Life
- Iran Ceasefire or Not, These 3 Companies Could Win
- Gold Is Testing Its 200-Day SMA—These 3 Mining Stocks Are the Play
- Summer Is Coming–But There’s No End in Sight for This Crypto Winter
- Oil Could Dip, But These 3 Energy Stocks Still Look Built to Win
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
